换一批
换一批Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant doses.
作者：
主题词
动物(Animals);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);血流速度(Blood Flow Velocity);血管(Blood Vessels);细胞存活(Cell Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物协同作用(Drug Synergism);酶抑制剂(Enzyme Inhibitors);男(雄)性(Male);一氧化氮合酶(Nitric Oxide Synthase);硝基精氨酸(Nitroarginine);大鼠(Rats);大鼠, 近交系(Rats, Inbred Strains);肉瘤, 实验性(Sarcoma, Experimental);二苯乙烯类(Stilbenes);时间因素(Time Factors);肿瘤负荷(Tumor Burden)
DOI
10.1158/1078-0432.CCR-08-2906
PMID
19470729
发布时间
2021-10-20
- 浏览15
Clinical cancer research
3781-90页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
